Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3194078 | Clinics in Dermatology | 2014 | 7 Pages |
Abstract
Vitiligo is an autoimmune depigmentation disorder that is estimated to affect about .5% of the worldwide population. Half of all cases begin in childhood. A variety of advances occurred in the past two decades that have enhanced the management of childhood vitiligo. This contribution reviews recent advances in vitiligo, including a better understanding of the pathogenesis and autoimmune comorbidities, description of the psychological comorbidities, a broader range of therapeutic options.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Nanette B. Silverberg,